RecruitingNCT07136220

A Pilot Study to Evaluate Equol and Its Effects on Menopausal Symptoms Experienced by Women in Singapore


Sponsor

Ang Seng Bin

Enrollment

300 participants

Start Date

Jul 2, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The main aim of this study is to evaluate the effect of equol on menopausal symptoms of women. Our hypothesis is that equol producers will have milder menopausal symptoms compared to non-equol producers. Equol is known as a metabolite produced by gut microbiota from soy-related diet and has estrogen-like activity compared to the isoflavones from soybean. Previous studies have shown that some women can produce equol from soy-related diet, but the others cannot because they don't have the bacteria which can metabolite daidzein in gut even if they take isoflavones thorough soybean products. This study will involve participants consuming a soy protein bar and collection of urine samples before and after its consumption.


Eligibility

Sex: FEMALEMin Age: 40 YearsMax Age: 60 Years

Inclusion Criteria1

  • \- Women aged 40-60

Exclusion Criteria10

  • Pregnant women
  • Allergy to Soy
  • Allergy to nuts
  • Consumed antibiotics within 7 days of the study
  • Has a history of autoimmune diseases
  • Has a history of thyroid disease
  • On medical treatment with hormone therapy, elective oestrogen receptors modulators
  • Consuming equol-containing supplements or food
  • Consuming painkillers
  • Consuming anti-depressants and/or sleeping pills

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERConsumption of soy protein bar

The participants will be provided one soy protein bar to consume after dinner on day 1.


Locations(1)

KK Women's and Children's Hospital

Singapore, Singapore

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07136220


Related Trials